European Stroke Initiative (EUSI) Recommendations for Stroke Management - The European Stroke Initiative Writing Committee

被引:56
作者
Hacke, W
Kaste, M
Olsen, TS
Orgogozo, JM
Bogousslavsky, J
机构
[1] Dept Neurol, D-69120 Heidelberg, Germany
[2] Univ Helsinki, Dept Neurol, SF-0029 Helsinki 29, Finland
[3] Bispebjerg Hosp, Dept Neurol, DK-2400 Copenhagen, Denmark
[4] Hop Pellegrin Tripode, Dept Neurol, F-33076 Bordeaux, France
[5] Univ Lausanne, CHU Vaudois, Serv Neurol, CH-1011 Lausanne, Switzerland
关键词
prophylaxis; rehabilitation; stroke; stroke treatment; thrombolytic therapy;
D O I
10.1046/j.1468-1331.2000.00137.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The European Stroke Initiative (EUSI) is the common body of stroke-related activities within the European Federation of Neurological Societies (EFNS), the European Neurological Society (ENS) and the European Stroke Council (ESC). The Executive committee of the EUSI has authorized the writing committee of the EUSI to create recommendations for stroke management covering all areas of stroke treatment. The recommendations are listed according to levels of evidence pre-specified and modified according to several proposals in the literature. The recommendations have been approved by the executive committees of the EUSI, the ESC, the EFNS and the ENS. They are called recommendations rather than guidelines in order to underline the large amount of individual decision making due to the fact that for many important questions, no data of high evidence level is available. The EUSI plans to review and update the recommendations on a regular basis.
引用
收藏
页码:607 / 623
页数:17
相关论文
共 85 条
[1]   RISK OF STROKE IN MALE CIGARETTE SMOKERS [J].
ABBOTT, RD ;
YIN, Y ;
REED, DM ;
YANO, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (12) :717-720
[2]   GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM A SPECIAL WRITING GROUP OF THE STROKE-COUNCIL, AMERICAN-HEART-ASSOCIATION [J].
ADAMS, HP ;
BROTT, TG ;
CROWELL, RM ;
FURLAN, AJ ;
GOMEZ, CR ;
GROTTA, J ;
HELGASON, CM ;
MARLER, JR ;
WOOLSON, RF ;
ZIVIN, JA ;
FEINBERG, W ;
MAYBERG, M .
STROKE, 1994, 25 (09) :1901-1914
[3]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[4]  
[Anonymous], 1989, Stroke, V20, P1407
[5]   COSTS AND GAINS IN STROKE PREVENTION - EUROPEAN PERSPECTIVE [J].
ASPLUND, K ;
MARKE, LA ;
TERENT, A ;
GUSTAFSSON, C ;
WESTER, PO .
CEREBROVASCULAR DISEASES, 1993, 3 :34-42
[6]  
ASPLUND K, 1987, STROKE, V18, P691
[7]  
Asplund K, 1997, BMJ-BRIT MED J, V314, P1151
[8]   Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis [J].
Barnett, HJM ;
Taylor, W ;
Eliasziw, M ;
Fox, AJ ;
Ferguson, GG ;
Haynes, RB ;
Rankin, RN ;
Clagett, GP ;
Hachinski, VC ;
Sackett, DL ;
Thorpe, KE ;
Meldrum, HE ;
Spence, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (20) :1415-1425
[9]  
Biller J, 1998, CIRCULATION, V97, P501
[10]   Stroke, statins, and cholesterol - A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors [J].
Blauw, GJ ;
Lagaay, AM ;
Smelt, AHM ;
Westendorp, RGJ .
STROKE, 1997, 28 (05) :946-950